Picture of Corteva logo

CTVA — Corteva News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapSuper Stock

Corteva Inc reports results for the quarter ended June 30 - Earnings Summary

Corteva Inc reports results for the quarter ended June 30 - Earnings Summary
  • Corteva Inc CTVA.N reported quarterly adjusted earnings of $2.30​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $2.20. The mean expectation of seventeen analysts for the quarter was for earnings of $2.22 per share. Wall Street expected results to range from $2.18 to $2.33 per share.

  • Revenue fell 1.2% to $6.38 billion from a year ago; analysts expected $6.58 billion.

  • Corteva Inc's reported EPS for the quarter was $1.81​.

  • The company reported quarterly net income of $1.21 billion.

  • Corteva Inc shares had risen by 5.5% this quarter and gained 33.3% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 4.1% in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy," 8 "hold" and no "sell" or "strong sell." The average consensus recommendation for the agricultural chemicals peer group is also "buy"

  • Wall Street's median 12-month price target for Corteva Inc is $94.00, about 5% above its last closing price of $89.34

This summary was machine generated from LSEG data July 31 at 06:27 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2026

2.22

2.30

Beat

Mar. 31 2026

1.17

1.50

Beat

Dec. 31 2025

0.22

0.22

Met

Sep. 30 2025

-0.53

-0.23

Beat

Recent news on Corteva

See all news